Cytoplasmic expression of the ELAV-like protein HuR as a potential prognostic marker in esophageal squamous cell carcinoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cytoplasmic expression of the ELAV-like protein HuR as a potential prognostic marker in esophageal squamous cell carcinoma
Authors
Keywords
HuR, mRNA stability, Esophageal squamous cell carcinoma, Prognosis
Journal
TUMOR BIOLOGY
Volume 35, Issue 1, Pages 73-80
Publisher
Springer Nature
Online
2013-07-19
DOI
10.1007/s13277-013-1008-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multiple Functions of the RNA-Binding Protein HuR in Cancer Progression, Treatment Responses and Prognosis
- (2013) Jun Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- High Expression of HuR in Cytoplasm, but Not Nuclei, Is Associated with Malignant Aggressiveness and Prognosis in Bladder Cancer
- (2013) Yasuyoshi Miyata et al. PLoS One
- Cytoplasmic HuR expression correlates with P-gp, HER-2 positivity, and poor outcome in breast cancer
- (2013) Zhongpeng Zhu et al. TUMOR BIOLOGY
- Multimodal treatment of esophageal cancer
- (2012) Florian Lordick et al. LANGENBECKS ARCHIVES OF SURGERY
- Emerging roles of RNA and RNA-binding protein network in cancer cells
- (2011) Mee-Young Kim et al. BMB Reports
- Role of RNA binding protein HuR in ductal carcinoma in situ of the breast
- (2011) Mira Heinonen et al. JOURNAL OF PATHOLOGY
- 7th Edition of the AJCC Cancer Staging Manual: Esophagus and Esophagogastric Junction
- (2010) Thomas W. Rice et al. ANNALS OF SURGICAL ONCOLOGY
- Increased expression of cytoplasmic HuR in familial adenomatous polyposis
- (2010) Lodewijk A.A. Brosens et al. CANCER BIOLOGY & THERAPY
- Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells
- (2010) Christine Hostetter et al. CANCER BIOLOGY & THERAPY
- Association between expression of embryonic lethal abnormal vision-like protein HuR and cyclooxygenase-2 in oral squamous cell carcinoma
- (2010) Jeong-Dan Cha et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Cytoplasmic HuR expression correlates with angiogenesis, lymphangiogenesis, and poor outcome in lung cancer
- (2010) Jun Wang et al. MEDICAL ONCOLOGY
- HuR expression is a marker of poor prognosis in renal cell carcinoma
- (2010) Hanna Ronkainen et al. TUMOR BIOLOGY
- Posttranscriptional regulation of cancer traits by HuR
- (2010) Kotb Abdelmohsen et al. Wiley Interdisciplinary Reviews-RNA
- HuR expression in the nucleus correlates with high histological grade and poor disease-free survival in ovarian cancer
- (2009) Xiaofang YI et al. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY
- HuR is exported to the cytoplasm in oral cancer cells in a different manner from that of normal cells
- (2009) H Hasegawa et al. BRITISH JOURNAL OF CANCER
- The Role of HuR in Gemcitabine Efficacy in Pancreatic Cancer: HuR Up-regulates the Expression of the Gemcitabine Metabolizing Enzyme Deoxycytidine Kinase
- (2009) C. L. Costantino et al. CANCER RESEARCH
- The Expression of RNA-Binding Protein HuR in Non-Small Cell Lung Cancer Correlates with Vascular Endothelial Growth Factor-C Expression and Lymph Node Metastasis
- (2009) Jun Wang et al. ONCOLOGY
- HuR and the bioenergetic signature of breast cancer: a low tumor expression of the RNA-binding protein predicts a higher risk of disease recurrence
- (2008) Álvaro D. Ortega et al. CARCINOGENESIS
- Overexpression of ELAV-like Protein HuR is Associated with Increased COX-2 Expression in Atrophy, High-grade Prostatic Intraepithelial Neoplasia, and Incidental Prostate Cancer in Cystoprostatectomies
- (2008) Francesca Barbisan et al. EUROPEAN UROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started